Back
BioVie Vs. Catalyst Pharmaceuticals Industry Stock Comparison
Sell
29
BIVI
BioVie
Last Price:
3.06
Seasonality Move:
18.19%
Sell
48
CPRX
Catalyst Pharmaceuticals
Last Price:
21.47
Seasonality Move:
4.48%
Sell
29
BioVie (BIVI)
is a Sell
Is BioVie a Buy, Sell or Hold?
- The current BioVie [BIVI] share price is $3.05. The Score for BIVI is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- BIVI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $21.48. The Score for CPRX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIVI Stock Price Chart
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $21.48
The current trend is relatively stagnant and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIVI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 54.95 | Buy |
| Chaikin Money Flow: | -1191404 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.59 - 3.27) | Buy |
| Bollinger Bands (100): | (1.88 - 3.84) | Buy |
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 48.92 | Sell |
| Chaikin Money Flow: | 621365 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.03 - 22.71) | Sell |
| Bollinger Bands (100): | (17.61 - 21.71) | Buy |
BIVI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.28 | Sell |
| 20-day SMA: | 2.96 | Buy |
| 50-day SMA: | 2.33 | Buy |
| 200-day SMA: | 4.61 | Sell |
| 8-day EMA: | 3.18 | Sell |
| 20-day EMA: | 2.95 | Buy |
| 50-day EMA: | 2.71 | Buy |
| 200-day EMA: | 7.62 | Sell |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.38 | Buy |
| 20-day SMA: | 22 | Sell |
| 50-day SMA: | 21.11 | Buy |
| 200-day SMA: | 17.57 | Buy |
| 8-day EMA: | 21.5 | Sell |
| 20-day EMA: | 21.67 | Sell |
| 50-day EMA: | 21.07 | Buy |
| 200-day EMA: | 18.25 | Buy |
BioVie Earnings Growth & BIVI Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.80 per share, and an increase next year of $7.39 per share.
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.
BioVie Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Catalyst Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||